Maintenance rituximab after autologous stem cell transplant for high-risk B-cell lymphoma induces prolonged and severe hypogammaglobulinemia

被引：46

作者：

Lim, SH ^{[1
]}

Zhang, Y

Wang, Z

Esler, WV

Beggs, D

Pruitt, B

Hancock, P

Townsend, M

机构：

[1] Texas Tech Univ, Hlth Sci Ctr, Div Hematol & Oncol, Amarillo, TX 79106 USA

[2] Don & Sybil Harrington Canc Ctr, Biotherapy & Stem Cell Transplant Program, Amarillo, TX USA

来源：

BONE MARROW TRANSPLANTATION | 2005年 / 35卷 / 02期

关键词：

D O I：

10.1038/sj.bmt.1704742

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 [生物物理学];

摘要：

引用

页码：207 / 208

页数：2

共 5 条

[1]

ASHIHARA E, 1994, BONE MARROW TRANSPL, V13, P377

[2]

Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma [J].

Horwitz, SM ;

Negrin, RS ;

Blume, KG ;

Breslin, S ;

Stuart, MJ ;

Stockerl-Goldstein, KE ;

Johnston, LJ ;

Wong, RM ;

Shizuru, JA ;

Horning, SJ .

BLOOD, 2004, 103 (03) :777-783

[3]

Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation [J].

Koehne, G ;

Zeller, W ;

Stockschlaeder, M ;

Zander, AR .

BONE MARROW TRANSPLANTATION, 1997, 19 (02) :149-156

[4]

Rituximab administration following autologous stem cell transplantation for multiple myeloma is associated with severe IgM deficiency [J].

Lim, SH ;

Zhang, YN ;

Wang, ZQ ;

Varadarajan, R ;

Periman, P ;

Esler, WV .

BLOOD, 2004, 103 (05) :1971-1972

[5]

Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow [J].

Talmadge, JE ;

Reed, E ;

Ino, K ;

Kessinger, A ;

Kuszynski, C ;

Heimann, D ;

Varney, M ;

Jackson, J ;

Vose, JM ;

Bierman, PJ .

BONE MARROW TRANSPLANTATION, 1997, 19 (02) :161-172

← 1 →